Z-0284-2024Class II
Philips Affiniti 70, Diagnostic Ultrasound System Model # 795210
Philips North America LLC / initiated 2023-10-09 / Completed / root cause: software
Philips Ultrasound, Inc. began a recall of Philips Affiniti 70, Diagnostic Ultrasound System Model # 795210 on . FDA classified it as Class II and gives the reason as "Their is the potential that diagnostic ultrasound systems operating with software version 10.0 may present a delayed image instead of a real time image". As of , the recall status on record is Completed, and MDM tags the root cause as software.
Recall record
- Recall number
- Z-0284-2024
- Classification
- Class II
- Status
- Completed
- Initiated
- Posted
- Recalling firm
- Philips North America LLC
- Product
- Philips Affiniti 70, Diagnostic Ultrasound System Model # 795210
- Product code
- IYN System, Imaging, Pulsed Doppler, Ultrasonic
- Reason for recall
- Their is the potential that diagnostic ultrasound systems operating with software version 10.0 may present a delayed image instead of a real time image.
- Root cause tag
- software
- FDA root cause
- Software design
- Action
- On October 9, 2023, Philips issued a Urgent Medical Device Correction notification to affected consignees. Philips asked consignees to take the following actions: 1. Identify if your firm has an affected product. 2. In the 2D tab in the system touchscreen, disable the AutoSCAN feature every time a transducer or a Transducer preset is selected to prevent the system from potentially experiencing image lag issue. The AutoSCAN feature is disabled when the button is not highlighted in amber. 3. Please complete and return the attached response form to Philips promptly and no later than 15 days from receipt. Completing this form confirms receipt of the Urgent Medical Device Correction Letter, understanding of the issue, and required actions to be taken. 4. Circulate this Urgent Medical Device Correction Letter to all users of this device so that they are aware of the issue. Please retain this letter with your system(s) and ensure the letter is in a place likely to be seen/viewed. 5. Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA's MedWatch Adverse Event Reporting program either online, or by regular mail, or by fax.
- Quantity in commerce
- 7 systems
- Distribution
- US: AZ, CA, CT, FL, GA, ID, IL, KY, MD, MT, NE, NV, OH, TN, TX, UT, VA OUS: Canada
- Product codes and lots
- Following serial numbers operating with software version 10.0. Model 795210/UDI: (01)00884838106611/Serial Numbers: US523F1930 US918F1158 US918F1159 US723F1377 US523F1496 US523F1497 US217F0292
Enforcement reports
One row per recalled product line| Recall number | Class | Status | Voluntary or mandated | Report date | Classified |
|---|---|---|---|---|---|
| Z-0283-2024 | Class II | Completed | Voluntary: Firm initiated | ||
| Z-0284-2024 | Class II | Completed | Voluntary: Firm initiated |
FIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
